P President Prof. Dr. Karl Broich 3704 P11 Media and Public Relations Research Council Research Co-ordinator P13 Ombudsman, Change and Idea Management Dr. Schulte, A. Pommer, M. N.N. 3261 Secr. 0228-99-307-3219/ -3204 Telefax: 0228-99-307-5514 P2 P3 European and International Affairs Controlling/ E-Processes PD Dr. Enzmann, H. Dr. Scheffler, M. 3689 VP 3309 3816 Vice President P21 CMDh Prof. Dr. Julia Stingl 3575 PharmNet.Bund Authorised Representative Dr. Menges, K. Dir. und Prof. 3458 Equal Opportunity Commissioner Mertens, R. Personnel Development Organisational Health Care Managment Division Z Division 1 Division 2 Division 3 Licensing 1 Licensing 2 Licensing 3 N.N. Dr. Horn, M. N.N. 4310 Secr. 3568 Secr. 3333 Z11 Human Resources 11 Validation Füllmann, J. Dr. Deicke, A. Z12 Budget 22 Gastroenterology/Metabolic Disorders/Radiology Dr. Dussa, J. Dr. Meyer, R. 4705 5844 5945 23 Diabetes Mellitus/ Cardiovascular System Eibenstein, M.A., G. 5660 Dr. Weise, M. 5482 Dr. Diller, M. 32 Antiinfectives/Antiallergics/ Dermatology/ENT Matz, S. 3355 42 Phytotherapeutic and Traditional Medicinal Products Reh, K. 5341 33 Anaesthesiology/Algesiology/Rheumatology/ Pneumology Dr. Schriever. J. 3304 43 Homoeopathic and Anthroposophic Medicinal Products Dr. von der Heidt, C. 3361 14 Parallel Imports 24 Oncology/Endocrinology 34 Neurology/Psychiatry/ Ophthalmology Kaiser, M. Dr. Brendler-Schwaab, S. 3526 Dr. Hermes, U. Dr. Rems, L. 3686 Z15 Library 3188 25 Genetic and Reproductive Toxicology Duda, A. PD Dr. Röhrdanz, E. 3235 3335 5975 4011 Z14 Documentation/Archiving Dr. Naumann-Winter 3466 Division 7 Division 8 Division 9 Federal Opium Agency Medical Devices Prof. Dr. Stingl, J. PD Dr. Sudhop, T. 3570 Secr. 3571 Dr. Kirchner, C. 5301 Dr. Paeschke, N. 4360 Secr. 3129 Prof. Dr. Stingl, J. ** 3570 52 Research Group Pharmacoepidemiology Prof. Dr. Stingl, J.** Dir.‘in u. Prof.‘in 3570 53 Research group on clinical safety of implants N.N. 4112 Secr. 3311 61 Clinical Trials Dr. Dr. Schrödter, A. 4320 Dr. Palissa, H. 4043 62 Scientific Advice 72 PRAC and other Commitees N.N. Dr. Huber, M. 63 Expert Panels Dr. Riedel, C. 4110 54 Biostatistics and Special Pharmacokinetics 64 Legal Affairs PD Dr. Benda, N. Völkel, H. 3514 4218 73 Post-authorisation Safety Studies, Pharmacovigilance Centres, Pharmacoepidemiology Dr. Straßmann, V. 3538 74 Signal Detection, Validation and Evaluation, ADR, Medication Safety 4519 65 Pharmacopoeia Dr. Norwig, J. 3274 Raunitschke, R. 3767 Z17 Internal Services, Property Matters 4236 * temporarily charged with the conduct of affairs/ interim performance of the funktions ** temporary in addition to the function as the Head of Division 92 Non-active Medical Devices 83 Control of Legal Trade in Narcotics and Psychotropic Substances II Dr. Greve, H. 5108 93 Active Medical Devices and In-vitro 84 Issues Relating to Pharmacists and Physicians Todt, M. Dr. Zündorf, J. 3202 Dr. Stößlein, E. 5384 94 Clinical Trials Dr. Schriever, U. * 4137 Dr. Lütkehermölle, W. 3216 5944 Social Advice Data Protection Commissioner Dexel, F. Claar, B. 4000 82 Control of Legal Trade in Narcotics and Psychotropic Substances I and Safety Measures Dr. Bräutigam, B. 5127 76 Risk Management I Dr. Grüger, Th. 5934 91 Project Management and Scientific Cross-sectional Issues Dr. Rämsch-Günther, N. 3997 75 Risk Assessment Procedures, Pharmacovigilance Inspections Dr. Zimmermann, L. 3232 77 Risk Management II Sent, J. 3820 5355 81 Control of Legal Trade in Precursors, Thalidomide Register Rohr, A. 5104 5984 Dr. Alesik, E. Dr. Lauer, W. Secr. 5325 3660 4517 Skiba, D. Dr. Cremer-Schaeffer, P. 3316 Secr. 5102 71 Project Management 66 Information Technology Representative for Disabled Employees Mertes-Engel, N. 3816 Pharmacovigilance Dr. Göben, J. Hulbert, F. Dr. Scheffler, M. 3762 Division 6 Z16 Special Legal Issues, Licensing Fees Head of the Staff Advisory Committee Hammerl, A. 3363 P33 Quality Management Scientific Services 35 Pharmaceutical Biotechnology, Quality Inspections Dr. Brake, B. 3482 Makran, S. P32 Controlling Research 5692 Youth and Trainees Council P31 E-Processes Division 5 51 Research Group Pharmcogenomics 41 Project Management Stadler, B.* 3133 12 Simplified Procedures I 13 Simplified Procedures II Meyer, U. 31 Project Management Norta, M. 3393 Ludwig-Merseburg, S. 3866 Z13 Organisational Issues Winterscheid, S. Secr. 3532 21 Project Management 5855 Division 4 Licensing 4 Complementary and Traditional Medicinal Products Prof. Dr. Knöss, W. 4172 5638 Secr. 5334 3315 Secr. 3314 Dr. Bachmann, P. 4163 P23 Scientific Quality/ Peer review Dr. Limberg, J. Secr. 0228-99-307-3576/ -3897 Telefax: 0228-99-307-3217 5211 Administration P22 COMP 4503 3732 Structure of the Federal Institute for Drugs and Medical Devices (BfArM) Kurt-Georg-Kiesinger-Allee 3 53175 Bonn Telefon: (0228) 99-307 – 30 Telefax: (0228) 99-307 – 5207 E-Mail: [email protected] Stand: 01.04.2016 5938
© Copyright 2024 ExpyDoc